LifeVantage (NASDAQ:LFVN – Get Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.700-0.800 for the period, compared to the consensus estimate of 0.700. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $205.8 million.
LifeVantage Price Performance
NASDAQ LFVN opened at $7.96 on Friday. LifeVantage has a 1 year low of $4.20 and a 1 year high of $9.14. The firm has a market cap of $101.10 million, a price-to-earnings ratio of 28.43 and a beta of 0.81. The company has a fifty day moving average price of $7.26 and a 200-day moving average price of $6.95.
LifeVantage (NASDAQ:LFVN – Get Free Report) last posted its earnings results on Wednesday, August 28th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.07). LifeVantage had a return on equity of 27.02% and a net margin of 1.75%. The firm had revenue of $48.93 million during the quarter.
LifeVantage Dividend Announcement
About LifeVantage
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
See Also
- Five stocks we like better than LifeVantage
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- What is the S&P 500 and How It is Distinct from Other Indexes
- Why Dell Can Continue Winning in AI and Beyond
- Canadian Penny Stocks: Can They Make You Rich?
- Veeva’s Stock Jumps on Stellar Q2 Results—Don’t Miss Out
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.